These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12480917)

  • 21. Enhancement of membrane-type 1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelatinase A on human squamous carcinoma cells co-cultured with human dermal fibroblasts.
    Sato T; Iwai M; Sakai T; Sato H; Seiki M; Mori Y; Ito A
    Br J Cancer; 1999 Jun; 80(8):1137-43. PubMed ID: 10376963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
    Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
    J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human oral squamous cell carcinomas: implications for lymph node metastasis.
    Shimada T; Nakamura H; Yamashita K; Kawata R; Murakami Y; Fujimoto N; Sato H; Seiki M; Okada Y
    Clin Exp Metastasis; 2000; 18(2):179-88. PubMed ID: 11235994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes.
    Baumann P; Zigrino P; Mauch C; Breitkreutz D; Nischt R
    Br J Cancer; 2000 Nov; 83(10):1387-93. PubMed ID: 11044366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads.
    Kinoshita T; Sato H; Okada A; Ohuchi E; Imai K; Okada Y; Seiki M
    J Biol Chem; 1998 Jun; 273(26):16098-103. PubMed ID: 9632662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heat shock suppresses membrane type 1-matrix metalloproteinase production and progelatinase A activation in human fibrosarcoma HT-1080 cells and thereby inhibits cellular invasion.
    Sato T; Sawaji Y; Matsui N; Sato H; Seiki M; Mori Y; Ito A
    Biochem Biophys Res Commun; 1999 Nov; 265(1):189-93. PubMed ID: 10548512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of matrix metalloproteinase 2 (MMP-2), membrane-type 1 MMP and tissue inhibitor of metalloproteinase 2 and activation of proMMP-2 in pancreatic duct adenocarcinomas in hamsters treated with N-nitrosobis(2-oxopropyl)amine.
    Iki K; Tsutsumi M; Kido A; Sakitani H; Takahama M; Yoshimoto M; Motoyama M; Tatsumi K; Tsunoda T; Konishi Y
    Carcinogenesis; 1999 Jul; 20(7):1323-9. PubMed ID: 10383907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form.
    Stanton H; Gavrilovic J; Atkinson SJ; d'Ortho MP; Yamada KM; Zardi L; Murphy G
    J Cell Sci; 1998 Sep; 111 ( Pt 18)():2789-98. PubMed ID: 9718371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of matrix metalloproteinase-14 in osteosarcoma cells by clodronate.
    Heikkilä P; Teronen O; Hirn MY; Sorsa T; Tervahartiala T; Salo T; Konttinen YT; Halttunen T; Moilanen M; Hanemaaijer R; Laitinen M
    J Surg Res; 2003 May; 111(1):45-52. PubMed ID: 12842447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage.
    Imai K; Ohta S; Matsumoto T; Fujimoto N; Sato H; Seiki M; Okada Y
    Am J Pathol; 1997 Jul; 151(1):245-56. PubMed ID: 9212749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell surface activation of progelatinase A (proMMP-2) and cell migration.
    Nagase H
    Cell Res; 1998 Sep; 8(3):179-86. PubMed ID: 9791731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Membrane type 1 matrix metalloproteinase-associated degradation of tissue inhibitor of metalloproteinase 2 in human tumor cell lines.
    Maquoi E; Frankenne F; Baramova E; Munaut C; Sounni NE; Remacle A; Noël A; Murphy G; Foidart JM
    J Biol Chem; 2000 Apr; 275(15):11368-78. PubMed ID: 10753951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular cholesterol regulates MT1 MMP dependent activation of MMP 2 via MEK-1 in HT1080 fibrosarcoma cells.
    Atkinson SJ; English JL; Holway N; Murphy G
    FEBS Lett; 2004 May; 566(1-3):65-70. PubMed ID: 15147870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2.
    Sato H; Kinoshita T; Takino T; Nakayama K; Seiki M
    FEBS Lett; 1996 Sep; 393(1):101-4. PubMed ID: 8804434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion.
    Sato H; Okada Y; Seiki M
    Thromb Haemost; 1997 Jul; 78(1):497-500. PubMed ID: 9198203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid activation of matrix metalloproteinase-2 by glioma cells occurs through a posttranslational MT1-MMP-dependent mechanism.
    Gingras D; Pagé M; Annabi B; Béliveau R
    Biochim Biophys Acta; 2000 Sep; 1497(3):341-50. PubMed ID: 10996658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.
    Fernandez-Catalan C; Bode W; Huber R; Turk D; Calvete JJ; Lichte A; Tschesche H; Maskos K
    EMBO J; 1998 Sep; 17(17):5238-48. PubMed ID: 9724659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The recombinant catalytic domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) induces activation of progelatinase A and progelatinase A complexed with TIMP-2.
    Lichte A; Kolkenbrock H; Tschesche H
    FEBS Lett; 1996 Nov; 397(2-3):277-82. PubMed ID: 8955363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The propeptide domain of membrane type 1 matrix metalloproteinase is required for binding of tissue inhibitor of metalloproteinases and for activation of pro-gelatinase A.
    Cao J; Drews M; Lee HM; Conner C; Bahou WF; Zucker S
    J Biol Chem; 1998 Dec; 273(52):34745-52. PubMed ID: 9856998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbohydrate-mediated regulation of matrix metalloproteinase-2 activation in normal human fibroblasts and fibrosarcoma cells.
    Gervasi DC; Raz A; Dehem M; Yang M; Kurkinen M; Fridman R
    Biochem Biophys Res Commun; 1996 Nov; 228(2):530-8. PubMed ID: 8920947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.